Actavis Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?
ACTAVIS LABS has one hundred and two approved drugs.
There are thirteen tentative approvals on ACTAVIS LABS drugs.
Drugs and US Patents for Actavis Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl Inc | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 079095-003 | Mar 24, 2009 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Labs Fl Inc | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 077686-006 | Mar 15, 2010 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Labs Fl Inc | ALPRAZOLAM | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 077198-003 | May 13, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Actavis Labs Fl Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 203755-001 | Aug 1, 2016 | AB3 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Labs Ut Inc | TESTOSTERONE | testosterone | GEL;TRANSDERMAL | 204570-002 | Jul 17, 2020 | AB2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Actavis Labs Fl Inc | LACOSAMIDE | lacosamide | TABLET;ORAL | 204855-001 | Jan 5, 2023 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Actavis Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.